SEAN BRYNJELSEN
CIK 1669976 · President & CEO · last filed 2026-05-29
SEAN BRYNJELSEN is a President & CEO who has filed 20 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider sold $3.8M of ETON on May 29, 2026. Across all open-market trades the lifetime net is −$7.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $27.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$27.13M
2
20
-$7.15M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ETON | President & CEO | 858,782 | $31.59 | $27.13M | -$7.15M | 18 | 2026-05-29 |
| Sagent Pharmaceuticals, Inc. (SGNT) Delisted | EVP, Business Development | 9,844 | — | — | $0 | 1 | 2016-04-06 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | ETON | Sell (S) | −120,000 | -$3.83M | EDGAR |
| 2026-01-14 | ETON | Mixed | −5,015 | -$77.2K | EDGAR |
| 2025-12-12 | ETON | Tax (F) | −6,732 | -$113.3K | EDGAR |
| 2025-06-05 | ETON | Sell (S) | −210,000 | -$3.59M | EDGAR |
| 2025-01-06 | ETON | Grant (A) | — | $0 | EDGAR |
| 2024-02-15 | ETON | Grant (A) | — | $0 | EDGAR |
| 2023-03-03 | ETON | Grant (A) | — | $0 | EDGAR |
| 2022-09-23 | ETON | Buy (P) | +10,000 | $21.0K | EDGAR |
| 2022-07-18 | ETON | Grant (A) | — | $0 | EDGAR |
| 2022-02-28 | ETON | Grant (A) | — | $0 | EDGAR |